Aptose Biosciences Inc.
Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Product Pipeline
Overview
Tuspetinib for AML
Luxeptinib for B-cell Tumors
Luxeptinib for Myeloid Tumors
Posters & Presentations
Clinical Trials
Overview
Luxeptinib for CLL & NHL
Luxeptinib for AML
Tuspetinib for AML
Expanded Access
News
Press Releases
Presentations
Events
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR
Governance
Join Us
Values & Culture
Perks & Benefits
Explore Careers
Contact
Posters & Presentations
Product Pipeline
Product Pipeline
Overview
Tuspetinib for AML
Luxeptinib for B-cell Tumors
Luxeptinib for Myeloid Tumors
Posters & Presentations
All
Poster
Presentation
August 21, 2025
Presentation
TUS Triplet TUSCANY Trial Update - August 2025
TUS Triplet TUSCANY Trial Update - August 2025:
View Presentation
June 12, 2025
Presentation
EHA 2025 - TUSCANY Study of Safety and Efficacy of Tuspetinib plus Standard of Care Venetoclax and Azacitidine in Study Participants with Newly Diagnosed AML Ineligible for Induction Chemotherapy
EHA 2025 - TUSCANY Study of Safety and Efficacy of Tuspetinib plus Standard of Care Venetoclax and Azacitidine in Study Participants with Newly Diagnosed AML Ineligible for Induction Chemotherapy:
View Presentation
May 5, 2025
Presentation
Aptose Corporate Presentation - Bloom Burton Conference
Aptose Corporate Presentation - Bloom Burton Conference:
View Presentation
March 11, 2025
Presentation
Aptose Corporate Presentation March 2025
Aptose Corporate Presentation March 2025:
View Presentation
January 13, 2025
Presentation
Aptose Corporate Presentation January 2025
Aptose Corporate Presentation January 2025:
View Presentation
November 7, 2024
Presentation
Aptose Corporate Presentation November 2024
Aptose Corporate Presentation November 2024:
View Presentation
July 26, 2024
Presentation
Aptose Corporate Presentation July 2024
Aptose Corporate Presentation July 2024:
View Presentation
May 3, 2024
Presentation
Aptose Corporate Presentation May 2024
Aptose Corporate Presentation May 2024:
View Presentation
December 26, 2023
Presentation
Aptose Corporate Presentation December 2023
Aptose Corporate Presentation December 2023:
View Presentation
1
2
3
4
Next